Systemic factors are involved in the pathogenesis of proteinuria-induced glomerulosclerosis in adriamycin nephrotic rats

Journal of the American Society of Nephrology

Volumn 10, Issue 11, 1999, Pages 2359-2366

  De Boer, Eric ^a   Navis, Gerjan ^a,b   Tiebosch, Anton T M ^a   De Jong, Paul E ^a   De Zeeuw, Dick ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CREATININE; DOXORUBICIN; PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG INDUCED DISEASE; FOCAL GLOMERULOSCLEROSIS; KIDNEY; MALE; NEPHROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; RAT;

EID: 0032752741     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Brenner BM, Meyer TW, Hostetter TH: Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 307: 652-659, 1982
2. Remuzzi G, Bertani T: Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int 38: 384-394, 1990
3. Bertani T, Cutillo F, Zoja C, Broggini M, Remuzzi G: Tubulointerstitial lesions mediate renal damage in adriamycin glomerulopathy. Kidney Int 30: 448-496, 1986
4. Hoyer JR, Mauer SM, Micheal AF: Unilateral renal disease in the rat. I. Clinical, morphologic, and glomerulur mesangial functional features of the experimental model produced by renal perfusion with aminonucleoside. J Lab Clin Med 85: 756-767, 1975
5. Bertani T, Andrcina P, Pozzoni R, Delaini F, Sacchi G, Thoua Y, Mecca G, Remuzzi G, Donati MB: Adriamycin-induced nephrotic syndrome in rats: Sequence of pathologic events. Lab Invest 46: 16-23, 1982
6. Greco BA, Breyer JA: Cholesterol as a predictor of progression in nondiabetic chronic renal disease. Contrib Nephrol 120: 48-61, 1997
7. Diamond JR, Kamovsky MJ: Exacerbation of chronic aminonucleoside nephrosis by dietary cholesterol supplementation. Kidney Int 32: 671-677, 1987
8. Joles JA, Rabelink TJ, Koomans HA: Role of lipids in progressive renal disease: Insights from the analbuminemic rat. Contrib Nephrol 120: 120-131, 1997
9. Keane WF, Kasiske BL, O'Donnell MP: The role of lipids in progressive glomerular disease. Adv Exp Med Biol 223: 81-87, 1987
10. Westenend PJ, Smits JF, Struyker-Boudier HA, Weening JJ: Acute renal vascular response to ACE-inhibition in two rat strains with different susceptibility to the development of glomerulosclerosis. Nephrol Dial Transplant 7: 602-607, 1992
11. Grond J, Muller EW, van Goor H, Weening JJ, Elema JD: Differences in puromycin aminonucleoside nephrosis in two rat strains. Kidney Int 33: 524-529, 1988
12. Grond J, Beukers JY, Schilthuis MS, Weening JJ, Elema JD: Analysis of renal structural and functional features in two rat strains with a different susceptibility to glomerular sclerosis. Lab Invest 54: 77-83, 1986
13. Wapstra FH, van Goor H, Navis GJ, de Jong PE, de Zeeuw D: Antiproteinuric effect predicts renal protection by angiotensin-converting enzyme inhibition in rats with established adriamycin nephrosis. Clin Sci 90: 393-401, 1996
14. Bunag RD: Measurement of blood pressure in rats. In: Handbook of Hypertension, edited by de Jong W. Amsterdam, Elsevier Science Publishers, 1984, pp 1-12
15. van Goor H, van de Horst MLC, Fidler V, Grond J: Glomerular macrophage modulation affects mesangial expansion in the rat after renal ablation. Lab Invest 66: 564-571, 1992
16. Okuda S, Yukinori O, Tsuruda H, Onoyama K, Fujimi S, Fujishima M: Adriamycin-induced nephropathy as a model of chronic progressive glomerular disease. Kidney Int 29: 502-511, 1986
17. Williams PS, Fass G, Bone JM: Renal pathology and proteinuria determine progression in untreated mild/moderate chronic renal failure. Q J Med 67: 343-354, 1988
18. Fogo A, Yoshiyuki Y, Glick AD, Homma T, Ichikawa I: Serial micropuncture analysis of glomerular function in two rat models of glomerular sclerosis. J Clin Invest 82: 322-330, 1988
19. Wapstra FH, Navis GJ, de Jong PE, de Zeeuw D: Prognostic value of the short-term antiproteinuric response to ACE-inhibition for prediction of GFR decline in patients with nondiabetic renal disease. Exp Nephrol 4: 47-52, 1996
20. Franco R, Gut A, Spadotto A, Goergette J, Gavras I, Gavras H: Pressor mechanisms in adriamycin-induced nephropathy with hypertension in rats. Hypertension 23: 246-249, 1994
21. Anderson S, Diamond JR, Karnovsky MJ, Brenner BM: Mechanisms underlying transition from acute glomerular injury to late glomerular sclerosis in a rat model of nephrotic syndrome. J Clin Invest 82: 1757-1768, 1988
22. Fries JW, Sandstrom DJ, Meyer TW, Rennke HG: Glomerular hypertrophy and epithelial cell injury modulate progressive glomerulosclerosis in the rat. Lab Invest 60: 205-218, 1989
23. Nagashima A, Okuda S, Tamaki K, Fujishima M: Influence of a high salt diet on glomerular injury and the preventive effects of amiloride in adriamycin nephropathy. Nephron 71: 87-94, 1995
24. Ichikawa I, Rennke HG, Hoyer JR, Badr KF, Schor N, Troy JL, Lechene CP, Brenner BM: Role for intrarenal mechanisms in the impaired salt excretion of experimental nephrotic syndrome. J Clin Invest 71: 91-103, 1983